研發(fā)與技術(shù)
R&D and Technology
-
查看詳情 >
2024-SCT-I10A combined with a bevacizumab biosimilar (SCT510) versus sorafenib in the first-line treatment of advanced hepatocellular carcinoma A randomized phase 3 trial
Hepatocellular carcinoma (HCC) is a significant health concern in ...
2024-06-20 -
查看詳情 >
2024-Rapid development and mass production of SARS-CoV-2 neutralizing chicken egg yolk antibodies with protective efficacy in hamsters
A novel coronavirus related to severe acute respiratory syndrome (...
2024-05-06 -
查看詳情 >
2024-Immunogenicity of Tetravalent Protein Vaccine against SARS-CoV-2 EG.5 Subvaraint A Phase 2 Trial
The evolutionary trajectory of Severe Acute Respiratory Syndrome C...
2024-02-08 -
查看詳情 >
2024-Finotonlimab with chemotherapy in recurrent or static head and neck cancer a randomized phase 3 trial
Immunotherapy combined with chemotherapy regimen has been shown t...
2024-06-02 -
查看詳情 >
2024-Efficacy safety and genomic analysis of SCT200 an anti-EGFR monoclonal antibody in patients with fluorouracil irinotecan and oxaliplatin refractory RAS and BRAF wild-type static
Colorectal cancer (CRC) the world’s third most common cancer...
2024-02-01 -
查看詳情 >
2024-Current status and future directions for the development of human papillomavirus vaccines
Human papillomavirus (HPV) infection can cause multiple types of ...
2024-06-20 -
查看詳情 >
2024-BiSpec Pairwise AI Guiding the Selection of Bispecific Antibody Target Combinations with pairwise learning and GPT augmentation
Malignant tumors represent a major global health challenge often c...
2024-05-07 -
查看詳情 >
2024-A Review of Protein-Based COVID-19 Vaccines From Monovalent to Multivalent Formulations
Since the World Health Organization (WHO) reported the first case ...
2024-05-25